Baker Brothers Advisors - TCR2 THERAPEUTICS INC ownership

TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 130 filers reported holding TCR2 THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,129,596
+50.2%
753,0640.0%0.01%
+20.0%
Q4 2022$752,160
-44.5%
753,0640.0%0.01%
-44.4%
Q3 2022$1,356,000
-37.9%
753,0640.0%0.01%
-25.0%
Q2 2022$2,184,000
+5.1%
753,0640.0%0.01%0.0%
Q1 2022$2,078,000
-40.8%
753,0640.0%0.01%
-29.4%
Q4 2021$3,509,000
+133.6%
753,064
+326.8%
0.02%
+142.9%
Q3 2021$1,502,000
-48.1%
176,4610.0%0.01%
-46.2%
Q2 2021$2,896,000
-25.7%
176,4610.0%0.01%
-23.5%
Q1 2021$3,896,000
+13.6%
176,461
+59.1%
0.02%
+30.8%
Q4 2020$3,430,000
+37.8%
110,888
-9.5%
0.01%
+30.0%
Q3 2020$2,490,000122,5320.01%
Other shareholders

There were no reported owners of TCR2 THERAPEUTICS INC in Q1 2021.

NameSharesValueWeighting ↓
View complete list of TCR2 THERAPEUTICS INC shareholders